Example #1: However, Health Canada, the American Association for the Advancement of Science, the American Medical Association, the National Academies of Sciences, the World Health Organization, and several other scientific and medical institutions from around the world have all concluded that genetically modified foods are safe to eat.
Expected output: 'entities: [{'span': 'Health Canada', 'entity': 'Organisation'}, {'span': 'American Association for the Advancement of Science', 'entity': 'Organisation'}, {'span': 'American Medical Association', 'entity': 'Organisation'}, {'span': 'National Academies of Sciences', 'entity': 'Organisation'}, {'span': 'World Health Organization', 'entity': 'Organisation'}]'

Example #2: Al-Farabi's school of philosophy breaks with the philosophy of Plato and Aristotle ... and ... moves from metaphysics to methodology, a move that anticipates modernity, and at the level of philosophy, Alfarabi unites theory and practice ... and in the sphere of the Politics he liberates practice from theory.
Expected output: 'entities: [{'span': 'Al-Farabi', 'entity': 'Person'}, {'span': 'school of philosophy', 'entity': 'Organisation'}, {'span': 'philosophy', 'entity': 'Discipline'}, {'span': 'Plato', 'entity': 'Person'}, {'span': 'Aristotle', 'entity': 'Person'}, {'span': 'metaphysics', 'entity': 'Theory'}, {'span': 'methodology', 'entity': 'Theory'}, {'span': 'Alfarabi', 'entity': 'Person'}, {'span': 'Politics', 'entity': 'Discipline'}]'

Example #3: She is awakened as a Soldier by the white cat Artemis when she is thirteen years old and instructed that she has a duty to become the beautiful warrior, Sailor V. Artemis explains that Venus and Earth are twin planets of about the same size and weight, that Venus is her mother star, and that she must protect Earth from its enemies.
Expected output: 'entities: [{'span': 'Artemis', 'entity': 'Misc'}, {'span': 'Sailor V. Artemis', 'entity': 'Person'}, {'span': 'Venus', 'entity': 'Astronomical Object'}, {'span': 'Earth', 'entity': 'Astronomical Object'}]'

Example #4: The widely used iGluSnFR consists of a circularly permuted Green fluorescent protein fused to a glutamate binding protein (GluBP) from a bacterium.
Expected output: 'entities: [{'span': 'iGluSnFR', 'entity': 'Misc'}, {'span': 'Green fluorescent protein', 'entity': 'Protein'}, {'span': 'glutamate binding protein', 'entity': 'Protein'}, {'span': 'GluBP', 'entity': 'Protein'}]'

Example #5: He was research assistant to Richard Harrison at the Royal London Hospital, then worked with J. D. H. Slater at the Middlesex Hospital from 1973 to 1974 and with A. Grabham at Kettering General Hospital for a year, before being appointed as assistant lecturer and honorary senior house orderly registrar in the School of Pathology at Middlesex Hospital Medical School (1975 to 1976).
Expected output: 'entities: [{'span': 'Richard Harrison', 'entity': 'Person'}, {'span': 'Royal London Hospital', 'entity': 'Organisation'}, {'span': 'J. D. H. Slater', 'entity': 'Person'}, {'span': 'Middlesex Hospital', 'entity': 'Organisation'}, {'span': 'A. Grabham', 'entity': 'Person'}, {'span': 'Kettering General Hospital', 'entity': 'Organisation'}, {'span': 'the School of Pathology at Middlesex Hospital Medical School', 'entity': 'Organisation'}]'

Example #6: The American Breeders Association held its first meeting in 1903 to discuss the new science of genetics that arose from Charles Darwin s theory of evolution and Gregor Mendel s discoveries of the laws of inheritance.
Expected output: 'entities: [{'span': 'American Breeders Association', 'entity': 'Organisation'}, {'span': 'Charles Darwin', 'entity': 'Scientist'}, {'span': 'theory of evolution', 'entity': 'Theory'}, {'span': 'Gregor Mendel', 'entity': 'Scientist'}]'

Example #7: Bio-active constituents of human milk that have been cataloged to possess immune-modulating capabilities include immunoglobulins, Lactoferrin, Lysozyme, oligosaccharide s, lipid s, cytokine s, hormone s, and growth factor s.
Expected output: 'entities: [{'span': 'immunoglobulins', 'entity': 'Protein'}, {'span': 'Lactoferrin', 'entity': 'Protein'}, {'span': 'Lysozyme', 'entity': 'Enzyme'}, {'span': 'oligosaccharide', 'entity': 'Misc'}, {'span': 'lipid', 'entity': 'Misc'}, {'span': 'cytokine', 'entity': 'Misc'}, {'span': 'hormone', 'entity': 'Misc'}, {'span': 'growth factor', 'entity': 'Misc'}]'

Example #8: The keratins include the following proteins of which KRT23, KRT24, KRT25, KRT26, KRT27, KRT28, KRT31, KRT32, KRT33A, KRT33B, KRT34, KRT35, KRT36, KRT37, KRT38, KRT39, KRT40, KRT71, KRT72, KRT73, KRT74, KRT75, KRT76, KRT77, KRT78, KRT79, KRT8, KRT80, KRT81, KRT82, KRT83, KRT84, KRT85 and KRT86 have been used to describe keratins past 20.
Expected output: 'entities: [{'span': 'keratins', 'entity': 'Misc'}, {'span': 'KRT23', 'entity': 'Protein'}, {'span': 'KRT24', 'entity': 'Protein'}, {'span': 'KRT25', 'entity': 'Protein'}, {'span': 'KRT26', 'entity': 'Protein'}, {'span': 'KRT27', 'entity': 'Protein'}, {'span': 'KRT28', 'entity': 'Protein'}, {'span': 'KRT31', 'entity': 'Protein'}, {'span': 'KRT32', 'entity': 'Protein'}, {'span': 'KRT33A', 'entity': 'Protein'}, {'span': 'KRT33B', 'entity': 'Protein'}, {'span': 'KRT34', 'entity': 'Protein'}, {'span': 'KRT35', 'entity': 'Protein'}, {'span': 'KRT36', 'entity': 'Protein'}, {'span': 'KRT37', 'entity': 'Protein'}, {'span': 'KRT38', 'entity': 'Protein'}, {'span': 'KRT39', 'entity': 'Protein'}, {'span': 'KRT40', 'entity': 'Protein'}, {'span': 'KRT71', 'entity': 'Protein'}, {'span': 'KRT72', 'entity': 'Protein'}, {'span': 'KRT73', 'entity': 'Protein'}, {'span': 'KRT74', 'entity': 'Protein'}, {'span': 'KRT75', 'entity': 'Protein'}, {'span': 'KRT76', 'entity': 'Protein'}, {'span': 'KRT77', 'entity': 'Protein'}, {'span': 'KRT78', 'entity': 'Protein'}, {'span': 'KRT79', 'entity': 'Protein'}, {'span': 'KRT8', 'entity': 'Protein'}, {'span': 'KRT80', 'entity': 'Protein'}, {'span': 'KRT81', 'entity': 'Protein'}, {'span': 'KRT82', 'entity': 'Protein'}, {'span': 'KRT83', 'entity': 'Protein'}, {'span': 'KRT84', 'entity': 'Protein'}, {'span': 'KRT85', 'entity': 'Protein'}, {'span': 'KRT86', 'entity': 'Protein'}]'

Example #9: Nihonium was first reported to have been created in 2003 by a Russian-American collaboration at the Joint Institute for Nuclear Research (JINR) in Dubna, Russia, and in 2004 by a team of Japanese scientists at Riken in Wakō, Japan.
Expected output: 'entities: [{'span': 'Nihonium', 'entity': 'Chemical Element'}, {'span': 'Russian-American', 'entity': 'Misc'}, {'span': 'Joint Institute for Nuclear Research', 'entity': 'Organisation'}, {'span': 'JINR', 'entity': 'Organisation'}, {'span': 'Dubna', 'entity': 'Location'}, {'span': 'Russia', 'entity': 'Country'}, {'span': 'Japanese', 'entity': 'Misc'}, {'span': 'Riken', 'entity': 'Organisation'}, {'span': 'Wakō', 'entity': 'Location'}, {'span': 'Japan', 'entity': 'Country'}]'

Example #10: After the war, he returned to research at the Cavendish Laboratory in Cambridge and completed building his first mass spectrograph that he reported on in 1919 and a fellow of the Royal Society and received the Nobel Prize in Chemistry the following year.
Expected output: 'entities: [{'span': 'Cavendish Laboratory', 'entity': 'Organisation'}, {'span': 'Cambridge', 'entity': 'University'}, {'span': 'fellow of the Royal Society', 'entity': 'Award'}, {'span': 'Nobel Prize in Chemistry', 'entity': 'Award'}]'

